Application of combined metabolic marker for screening diabetes mellitus and kit of combined metabolic marker
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- DALIAN INST OF CHEM PHYSICS CHINESE ACAD OF SCI
- Publication Date
- 2021-06-04
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The present invention relates to novel uses of known metabolites. The present invention relates to the combination of galactose, 1,5-sorbitol, N-acetylglucosamine and 2-hydroxybutyric acid in serum as a combined marker for diagnosing diabetes, and relates to the detection and screening of diabetes in the test population Patient kit. Background technique
[0002] Diabetes is a global health problem, and its incidence is increasing year by year, but the diagnosis rate is less than 50%. Diabetic patients have various complications due to abnormal insulin function or secretion. China is the country with the largest number of diabetic patients in the world. If it cannot be intervened and treated in time, it will increase the burden on the national public health system. Currently, fasting blood glucose and the oral 75g glucose tolerance (OGTT) test are the gold standard for diagnosing diabetes. However, since the OGTT test needs to collect and test blood...